In this paper, golodirsen’s mechanism of action was investigated by comparing treated with non-treated differentiated MyoD lentivirally - transfected fibroblasts [21, 22] from 25 DMD patients previously recruited into a phase I/II trial on golodirsen [23]. Here, MYOD1 is linked to Duchenne muscular dystrophy.